Navigation Links
UCSF Launches Nationwide Clinical Trial Matching Web Site for Breast Cancer
Date:10/14/2008

SAN FRANCISCO, Oct. 14 /PRNewswire/ -- The University of California, San Francisco (UCSF) Center of Excellence for Breast Cancer Care today launched BreastCancerTrials.org, a free, non-profit, clinical trial matching service that provides nationwide information for individuals diagnosed with or at risk for breast cancer.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/breastcancerclinicaltrials/34846/

BreastCancerTrials.org is the only clinical trial matching service dedicated exclusively to breast cancer, with an online database that includes information about clinical trials taking place at more than 1100 medical facilities across the country. The site is an outgrowth of a successful regional pilot initiated by the UCSF Carol Franc Buck Breast Care Center, the National Cancer Institute (NCI) and patient advocates. The nationwide launch of BreastCancerTrials.org is made possible by a grant from The Safeway Foundation, the philanthropic arm of Safeway, Inc.

"BreastCancerTrials.org is an exciting, win-win development for the breast cancer community," said Laura Esserman, M.D., Director of the UCSF Center of Excellence for Breast Cancer Care and the UCSF Carol Franc Buck Breast Care Center. "Every advance in our understanding and treatment of breast cancer has come from clinical trial results. The more we can empower our patients to find out about and participate in trials, the faster we will be able to complete trials, and the sooner this new knowledge will translate into better care and outcomes for all patients."

By making information about trials easy to find, BreastCancerTrials.org hopes to make consideration of clinical trial participation the norm rather than the exception. By helping patients find and evaluate trials for which they may be eligible, and by encouraging and facilitating patient enrollment in trials, BreastCancerTrials.org intends to increase the rate at which new treatments and procedures are made available to all breast cancer patients, as well as those at heightened risk for developing the disease.

"I made the decision to enroll in a clinical trial because I wanted to explore all of my treatment options," said breast cancer survivor and BreastCancerTrials.org user Isabel Hemming of Los Angeles, California. "Through BreastCancerTrials.org, it was easy to find several trials that were seeking women with the type of breast cancer that I was diagnosed with, and -- after talking to my doctor -- I was able to identify one that I was eligible for. I hope that my participation in the trial may one day result in improved treatment for other women like me."

BreastCancerTrials.org users enter a detailed health history, which matches them to trials that are specific to their personal health situation. Information on whom to contact for further discussion about a trial and additional criteria for enrollment is also provided. Individuals can use BreastCancerTrials.org on a one-time basis or store their health history on secure servers for continual matching to newly listed trials. Information stored on BreastCancerTrials.org is never sold or shared with external parties.

According to the Clinical Research Roundtable at the Institute of Medicine, very few patients are currently aware that they are eligible for participation in research studies, making recruitment challenging for trial sites.(1) By helping individuals evaluate trials as a routine option for care, BreastCancerTrials.org hopes to increase the rate at which new treatments and procedures are developed and made available to individuals at all stages of their disease.

About BreastCancerTrials.org

BreastCancerTrials.org operates as an independent non-profit corporation.

BreastCancerTrials.org was initially co-developed as a regional pilot by the National Cancer Institute and the University of California, San Francisco Center of Excellence for Breast Cancer Care (COE-BCC), an integral program of the UCSF Carol Franc Buck Breast Care Center, and a core program of the UCSF National Center of Excellence in Women's Health and the UCSF Helen Diller Family Comprehensive Cancer Center. With the success of the pilot, BreastCancerTrials.org was incorporated as a separate non-profit corporation dedicated to the continuing delivery of this service.

For further information, visit the site at http://www.BreastCancerTrials.org.

About Breast Cancer

According to the American Cancer Society's Breast Cancer Facts & Figures 2007-2008, breast cancer is a progressive and potentially deadly disease that will affect about 182,460 women in 2008. About 40,480 women will die from breast cancer this year, and there are about 2.5 million breast cancer survivors in the United States. Additional research is critical and necessary to ensure that the millions affected by or at risk for breast cancer receive the proper treatment they need, according to ACS.

About the University of California, San Francisco

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For more information on UCSF, visit http://www.ucsf.edu.

(1) "Central Challenges Facing the National Clinical Research Enterprise." Journal of the American Medical Association, Vol 289, No. 10. March 12, 2003.


'/>"/>
SOURCE BreastCancerTrials.org
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. HealthInsuranceFinders.com Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... 06, 2016 , ... The Behavioral Health Center of Excellence ... organization as a top behavioral service provider in the country. The award celebrates ... satisfaction and qualifications, and consumer satisfaction. These areas are measured via a wide-ranging ...
(Date:12/6/2016)... ... December 06, 2016 , ... Experimentation involving human stem ... largely due to its potential for revolutionizing human disease treatment. There are multiple ... pluripotent stem cells (hiPSCs). , Both platforms have distinct advantages and disadvantages, ...
(Date:12/6/2016)... ... 06, 2016 , ... METTLER TOLEDO has launched its online ... white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, brochures, datasheets, user ... documents, webinars and videos available online, visit the METTLER TOLEDO Expertise Library ...
(Date:12/6/2016)... ... ... 'Tis the season for family, festivity, food and fun! Temptation abounds, and ... eating healthy, staying active, and taking medication and doing daily foot health checks (a ... "Shopping trips, parties and family gatherings can take their toll on our feet during ...
(Date:12/6/2016)... B.C., Canada (PRWEB) , ... December 06, 2016 ... ... (STC) announce the availability of the newly updated International Audit Protocol Consortium (IAPC) ... use IAPC EHS audit protocols to understand the scope of their EHS regulatory ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Nov. 29, 2016 Several leading Alzheimer,s ... Accera, Inc. at 11 a.m. EST on ... Conference on Clinical Trials for Alzheimer,s Disease (CTAD). The ... in Alzheimer,s disease and therapeutic targets that address deficient ... "Following the recent failure of another therapy targeting the ...
(Date:12/5/2016)... , Dec 5, 2016 Research ... Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease ... - Global Forecasts to 2021" report to their offering. ... , , ... USD 730.7 Million in 2021 from USD 574.8 Million in 2016, ...
(Date:12/5/2016)... PUNE, India , December 5, 2016 ... Market by Product Type and by Application - Global Opportunity Analysis and Industry ... in 2015, and is expected to reach $5,255 million by 2022, growing at ... market in 2015 with more than four-fifths share. ... ...
Breaking Medicine Technology: